Researcher Resources

At the Neuroendocrine Tumor Research Foundation, we view our grantees not just as funding recipients, but as essential partners in our mission to discover cures and more effective treatments for neuroendocrine cancer. We know your time is best spent in the lab and the clinic, so we have designed this page to be a central, streamlined resource for everything you need to manage your grant. Here, you will find quick access to portals, guidelines, and NETRF community opportunities to support your ongoing research. Thank you for your dedication, innovation, and
relentless pursuit of a cure.

Grants Management and Reporting
  • Award Budget and Expenditure Policy
  • Open Access Policy

    1. NETRF is committed to sharing research information to ensure research transparency and enable unrestricted access to research results. Grant recipients must submit all publications, including non-research articles such as review articles, that were in part or fully funded by NETRF as a preprint to bioRxiv, medRxiv or a similar preprint sharing service prior to or at the time of initial journal submission.
  • Intellectual Property Policy

    1. IP rights are governed by the grant agreement signed by the grantee’s institution.
    2. Example of IP language that may be in grant contract.
  • Resource and Data Sharing Policy

    1. Research resource sharing. Grant recipients that create unique research resources, including but not limited to: model organisms, cell lines, plasmids, protocols, software, and data, using NETRF funds, are required to share such resources within the scientific community. NETRF expects that, where available, resources will be deposited and archived in standard repositories. Grant recipients who create new plasmids, or other nucleic acid-based vectors and reagents that may be useful to the neuroendocrine cancer scientific community, should consider depositing them to Addgene. Grant recipients who have created new cell lines and other disease models are recommended to submit them to reputable repositories. Resources should be shared openly with the research community no later than the date of publication or within twelve months after the end of the grant funding, whichever comes first. NETRF should be informed so they can help facilitate resource-sharing.
    2. Data Availability. For publications arising from the Project, Grantee will deposit underlying de-identified data and code in a recognized repository (where ethically and legally permissible) no later than the publication date, with appropriate metadata.
  • NETRF Acknowledgement and Attribution Policy
    1. Grantee shall provide acknowledgement of the Foundation’s funding in any and all publications and marketing materials issued by Grantee or its assignees and licensees concerning the Invention, including without limitation all public disclosures, scientific or journal articles, abstracts, poster or similar materials. Grantee must acknowledge the Foundation’s support by including a statement in substantially the following form: “Supported by a grant from the Neuroendocrine Tumor Research Foundation.”
  • NETRF Annual Research Symposium Requirement
    1. Current grantees are required to allocate funding from their award to attend the NETRF Annual Research Symposium. This is a significant requirement, as our supporting funders expect to hear from and interact with their awardees. We provide ample time for planning, but if attendance is not possible, please contact the Research Team to discuss your circumstances. In such cases, we strongly encourage you to send a laboratory colleague or trainee who is familiar with the project and can attend and present at the Symposium on your behalf.

NEN Cell Lines & Models (directory of available cell lines, organoids, animal models, etc.)

Sign Up

Researcher News and Grant Opportunities

Sign up below to receive grant announcements, funding deadlines, NETRF researcher events, and collaboration opportunities. This list is intended for researchers, clinicians, and pharma partners.

"*" indicates required fields

Address*